Similarly, high Bcl-2 levels have been detected in a variety of tumor types, including small cell lung, melanoma, breast, prostate, colorectal, and bladder cancers, and especially in human lymphoid malignancies (Dai et al., 2016). This evidence concerns the gene BCL2 and urinary bladder cancer.